Daiichi Sankyo-Sarah Cannon Research Institute Announce Strategic Collaboration
Tom Held, Vice President, Head, Antibody Drug Conjugate Task Force, Oncology Research and Development, Daiichi Sankyo commented, "We look forward to partnering with Sarah Cannon to…